The Guinea Pig Model of Diisocyanate Sensitization: I. Physiologic Studies
-
1982/11/01
-
Details
-
Personal Author:
-
Description:The qualitative and quantitative properties of diisocyanate-specific IgE antisera derived from an IgE-susceptible strain of guinea pigs were investigated by passive sensitization of immunologically virgin recipient animals. These animals received infusions of antisera 48 hr before intravenous challenge with specific ligands conjugated to an unrelated carrier protein, human transferrin. The pulmonary response was sublethal and could be measured by physiologic methods. Various measurements were obtained in anesthetized guinea pigs placed in a whole-body pressure plethysmograph. Tidal volume (Vt), dynamic compliance (CL dyn), and pulmonary conductance (GL) were calculated from simultaneous recordings of transpulmonary pressure. Vt, and flow. Frequency at 1 and 2 min after intravenous challenge were also measured. Mean respiratory frequency was significantly increased in experimental animals 1 min after challenge with homologous hapten-protein conjugates, while maximum changes of Vt, cL dyn, and GL occurred 2 min after intravenous challenges. A preponderant number of physiologic abnormalities occurred in animals challenged with homologous hapten-protein conjugates. The mean percent change of Vt and CL dyn from baseline levels was significantly decreased after intravenous challenges with homologous ligands in animals passively sensitized with both hexamethylene diisocyanate-(HDI) and toluene diisocyanate-specific antisera. However, decrease of mean GL after challenge with homologous hapten-protein conjugates was significant only in animals passively sensitized with HDI-specific antisera. When the number of positive postchallenge pulmonary function responses was compared with the mean geometric titers of IgE antisera, it was observed that moderate or severe physiologic responses were associated with infusions of IgE antisera having titers of 160 or greater. These experiments suggest that antibody concentration may be a critical determinant in distinguishing between clinical, subclinical and nonreactive states induced by diisocyanate sensitization. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0091-6749
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Pages in Document:393-398
-
Volume:70
-
Issue:5
-
NIOSHTIC Number:nn:20061064
-
Citation:J Allergy Clin Immunol 1982 Nov; 70(5):393-398
-
Contact Point Address:I. Leonard Bernstein, M.D., University of Cincinnati Medical Center, 231 Bethesda Ave., Cincinnati, OH 45267
-
CAS Registry Number:
-
Federal Fiscal Year:1983
-
Performing Organization:University of Cincinnati, Cincinnati, Ohio
-
Peer Reviewed:True
-
Start Date:19780701
-
Source Full Name:Journal of Allergy and Clinical Immunology
-
End Date:19810630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:57b5c1a0bc1f58163b1314129a41c6c1873070516f71588bc2fb12a561c7bcfb4aecd0fa788bcf7321d4b4eae69964eb7974da4a46d25d50db1233f9a195fe54
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like